ReviewMagyar onkologia2026
[Anthracycline use in breast cancer based on our current knowledge].
Review in Magyar onkologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anthracyclines have been a standard component of the curative treatment of breast cancer for decades. Due to the emergence of new anticancer drugs (taxanes, immunotherapy, antibody-drug conjugates) and potentially life-threatening and long-term side effects of anthracyclines, the range of indications for their use has narrowed in recent years and seems to be becoming clearer. The classification of breast cancers according to molecular subgroups and the ever-expanding clinical data allow the choice of applied treatments to be increasingly individualized, which has led to the decline of anthracyclines in most breast cancer subtypes. Our goal with our summary work is to facilitate everyday decisions regarding the use of anthracyclines by summarizing the available clinical evidence.
Indexed as
Identifiers
42731007PMC13577713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.